Research & Development
EMA to decide on Pfizer's COVID-19 booster shot in early October
23 September 2021 -

The European Medicines Agency (EMA), the EU's drug regulator, is expected to decide in early October on the possible use of a booster dose of the Pfizer (NYSE:PFE)/BioNTech (Nasdaq:BNTX) COVID-19 vaccine, Reuters news agency reported on Thursday, citing a source with direct knowledge of the matter.

According to the source, this will be the EMA's first decision on COVID-19 vaccine boosters.

The regulator said on 6 September that it had begun its evaluation of data submitted by Pfizer and BioNTech for a booster dose to be given six months after the second dose in people 16 years of age and older.



Related Headlines